JWM
ENTA icon

JPL Wealth Management’s Enanta Pharmaceuticals ENTA Stock Holding History

JPL Wealth Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76 Buy
+6
New +$80 ﹤0.01% 1483

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JPL Wealth Management's ENTA Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 6 shares worth $76. The stake represents ﹤0.01% of the portfolio and ranks #1483 among its holdings.

132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • JPL Wealth Management held 6 shares of Enanta Pharmaceuticals worth $76 as of Q1 2026.
  • Enanta Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1483 holding.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.